<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038485/" ref="ordinalpos=3504&amp;ncbi_uid=6201613&amp;link_uid=PMC4038485" image-link="/pmc/articles/PMC4038485/figure/pgen-1004371-g008/" class="imagepopup">Figure 8. Graphic representation of how RP mutations result in autophagy and insulin <span class="highlight" style="background-color:">pathway</span> inhibition..  From: Ribosomal Protein Mutations Induce Autophagy through S6 Kinase Inhibition of the Insulin <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">In normal cells, insulin signals through the insulin receptor substrate (IRS) to the PI3-kinase/AKT pathway in a manner that inhibits autophagy and increases the expression of glucose transporters on the cell membrane. In cells with RP loss, an increase of ROS stabilizes p53 and induces phosphorylation of S6 kinase. This hyper-phosphorylation of S6 kinase results in degradation of IRS and a decrease of insulin signaling to PI3-kinase and AKT. This loss of AKT activation in turn releases the inhibition of autophagy and reduces glycolysis.</div></div>